Ryo Koyama Selected Research

Ryo Koyama Research Topics

Disease

11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 09/2012
5	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2021 - 10/2008
2	Neoplasms (Cancer) 11/2021 - 01/2021
2	Adenocarcinoma of Lung 11/2021 - 09/2016
2	Hypersensitivity (Allergy) 03/2020 - 02/2020
2	Disease Progression 01/2017 - 10/2015
2	Dyspnea (Shortness of Breath) 04/2016 - 10/2008
1	Organizing Pneumonia 11/2021
1	Pain (Aches) 10/2021
1	Tongue Neoplasms (Tongue Neoplasm) 10/2021
1	Diarrhea 01/2021
1	Neuralgia (Stump Neuralgia) 03/2020
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Leukopenia 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Febrile Neutropenia 01/2017
1	Anorexia 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 11/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2016
1	Necrosis 11/2016
1	Neoplasm Metastasis (Metastasis) 09/2016
1	Chemical and Drug Induced Liver Injury 01/2014
1	Cough 10/2008
1	Infections 10/2008
1	Bacterial Pneumonia 10/2008
1	Hypoxia (Hypoxemia) 10/2008
1	Uveitis 10/2006
1	Hypesthesia (Numbness) 10/2006
1	Paralysis (Palsy) 10/2006
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2004

Drug/Important Bio-Agent (IBA)

3	Bevacizumab (Avastin)FDA Link 07/2021 - 04/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2016
3	Pemetrexed (MTA)FDA Link 10/2015 - 12/2012
2	SteroidsIBA 11/2021 - 04/2016
2	PlatinumIBA 07/2021 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
2	Docetaxel (Taxotere)FDA Link 01/2017 - 10/2015
2	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 01/2004
2	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2016 - 01/2014
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2016 - 09/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2016 - 10/2006
1	Prednisolone (Predate)FDA LinkGeneric 11/2021
1	Immune Checkpoint InhibitorsIBA 11/2021
1	pembrolizumabIBA 11/2021
1	B7-H1 AntigenIBA 11/2021
1	Adenosine Triphosphate (ATP)IBA 10/2021
1	atezolizumabIBA 07/2021
1	AfatinibIBA 01/2021
1	osimertinibIBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 03/2020
1	Minocycline (Cyclops)FDA LinkGeneric 03/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2020
1	CrizotinibIBA 01/2020
1	alectinibIBA 01/2020
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2017
1	resminostatIBA 01/2017
1	Hydroxamic Acids (Hydroxamic Acid)IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Cytotoxins (Cytolysins)IBA 01/2017
1	Histone Deacetylase InhibitorsIBA 01/2017
1	Deoxyribonuclease I (Nickase)IBA 11/2016
1	Deoxyribonucleases (DNase)FDA Link 11/2016
1	ChromatinIBA 11/2016
1	EndonucleasesIBA 11/2016
1	Streptozocin (Streptozotocin)FDA Link 11/2016
1	caspase-activated deoxyribonucleaseIBA 11/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2016
1	Pharmaceutical PreparationsIBA 04/2016
1	Monoclonal AntibodiesIBA 04/2016
1	Furosemide (Lasix)FDA LinkGeneric 12/2012
1	Mannitol (Osmitrol)FDA LinkGeneric 12/2012
1	Cisplatin (Platino)FDA LinkGeneric 12/2012
1	MagnesiumIBA 12/2012
1	Gefitinib (Iressa)FDA Link 09/2012
1	Methylprednisolone FDA LinkGeneric 10/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2008
1	Surface-Active Agents (Surfactants)IBA 01/2004
1	Protein CIBA 01/2004

Therapy/Procedure

6	Therapeutics 11/2021 - 10/2006
4	Drug Therapy (Chemotherapy) 07/2021 - 10/2015
1	Complementary Therapies (Alternative Medicine) 03/2020
1	Spinal Cord Stimulation 03/2020
1	Combination Drug Therapy (Combination Chemotherapy) 12/2012
1	X-Ray Film 10/2008
1	Intravesical Administration 10/2008